Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous tranexamic acid in craniotomy for meningioma resection
TCTR20241223001Phase 2Completed
- Sponsor
- Office of Research and Development, Phramongkutklao Hospital and College of Medicine
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tranexamic acid in meningioma, sponsored by Office of Research and Development, Phramongkutklao Hospital and College of Medicine. Started Dec 2024; status: completed.
02
Drugs
tranexamic acid
03
Conditions
meningioma
Beyond the preview
Go deeper on TCTR20241223001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20241223001.